Annual SG&A
$4.21 M
-$1.92 M-31.33%
31 December 2023
Summary:
Hoth Therapeutics annual selling, general & administrative expenses is currently $4.21 million, with the most recent change of -$1.92 million (-31.33%) on 31 December 2023. During the last 3 years, it has fallen by -$200.80 thousand (-4.55%). HOTH annual SG&A is now -35.91% below its all-time high of $6.57 million, reached on 31 December 2021.HOTH Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.23 M
+$155.20 K+14.38%
30 September 2024
Summary:
Hoth Therapeutics quarterly selling, general & administrative expenses is currently $1.23 million, with the most recent change of +$155.20 thousand (+14.38%) on 30 September 2024. Over the past year, it has increased by +$116.10 thousand (+10.38%). HOTH quarterly SG&A is now -55.25% below its all-time high of $2.76 million, reached on 31 December 2019.HOTH Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$223.30 M
-$7.51 M-3.48%
30 September 2024
Summary:
Hoth Therapeutics TTM selling, general & administrative expenses is currently -$223.30 million, with the most recent change of -$7.51 million (-3.48%) on 30 September 2024. Over the past year, it has dropped by -$228.68 million (-4247.27%). HOTH TTM SG&A is now -5586.64% below its all-time high of $6.39 million, reached on 31 December 2021.HOTH TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOTH Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.3% | +10.4% | -4247.3% |
| 3 y3 years | -4.5% | +13.2% | -4087.6% |
| 5 y5 years | +245.0% | +24.9% | -8851.3% |
HOTH Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.9% | at low | -36.9% | +57.6% | -122.7% | at low |
| 5 y | 5 years | -35.9% | +245.0% | -55.3% | +95.3% | -801.7% | at low |
| alltime | all time | -35.9% | +245.0% | -55.3% | +481.6% | -5586.6% | at low |
Hoth Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.23 M(+14.4%) | $4.69 M(+2.5%) |
| June 2024 | - | $1.08 M(-32.0%) | $4.57 M(+0.5%) |
| Mar 2024 | - | $1.59 M(+102.8%) | $4.55 M(+7.9%) |
| Dec 2023 | $4.21 M(-31.3%) | $783.20 K(-30.0%) | $4.21 M(-21.8%) |
| Sept 2023 | - | $1.12 M(+5.9%) | $5.38 M(-1.8%) |
| June 2023 | - | $1.06 M(-15.8%) | $5.48 M(-4.1%) |
| Mar 2023 | - | $1.25 M(-35.9%) | $5.72 M(-6.8%) |
| Dec 2022 | $6.13 M(-6.7%) | $1.96 M(+60.8%) | $6.13 M(+9.5%) |
| Sept 2022 | - | $1.22 M(-5.9%) | $5.60 M(+2.3%) |
| June 2022 | - | $1.29 M(-22.7%) | $5.48 M(-2.2%) |
| Mar 2022 | - | $1.67 M(+17.4%) | $5.60 M(-12.4%) |
| Dec 2021 | $6.57 M | $1.42 M(+30.5%) | $6.39 M(+14.1%) |
| Sept 2021 | - | $1.09 M(-22.9%) | $5.60 M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $1.42 M(-42.5%) | $5.93 M(+4.8%) |
| Mar 2021 | - | $2.46 M(+289.3%) | $5.66 M(+35.5%) |
| Dec 2020 | $4.41 M(-12.7%) | $632.30 K(-55.4%) | $4.17 M(-33.8%) |
| Sept 2020 | - | $1.42 M(+23.9%) | $6.30 M(+7.3%) |
| June 2020 | - | $1.14 M(+16.8%) | $5.87 M(+8.5%) |
| Mar 2020 | - | $980.10 K(-64.5%) | $5.41 M(+7.1%) |
| Dec 2019 | $5.06 M(+314.2%) | $2.76 M(+179.1%) | $5.06 M(+98.2%) |
| Sept 2019 | - | $988.50 K(+44.0%) | $2.55 M(+43.7%) |
| June 2019 | - | $686.60 K(+10.4%) | $1.78 M(+15.6%) |
| Mar 2019 | - | $622.00 K(+144.4%) | $1.54 M(+25.8%) |
| Dec 2018 | $1.22 M | $254.50 K(+19.9%) | $1.22 M(+26.3%) |
| Sept 2018 | - | $212.30 K(-52.5%) | $966.40 K(+28.2%) |
| June 2018 | - | $446.70 K(+45.3%) | $754.10 K(+145.3%) |
| Mar 2018 | - | $307.40 K | $307.40 K |
FAQ
- What is Hoth Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Hoth Therapeutics?
- What is Hoth Therapeutics annual SG&A year-on-year change?
- What is Hoth Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Hoth Therapeutics?
- What is Hoth Therapeutics quarterly SG&A year-on-year change?
- What is Hoth Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Hoth Therapeutics?
- What is Hoth Therapeutics TTM SG&A year-on-year change?
What is Hoth Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of HOTH is $4.21 M
What is the all time high annual SG&A for Hoth Therapeutics?
Hoth Therapeutics all-time high annual selling, general & administrative expenses is $6.57 M
What is Hoth Therapeutics annual SG&A year-on-year change?
Over the past year, HOTH annual selling, general & administrative expenses has changed by -$1.92 M (-31.33%)
What is Hoth Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of HOTH is $1.23 M
What is the all time high quarterly SG&A for Hoth Therapeutics?
Hoth Therapeutics all-time high quarterly selling, general & administrative expenses is $2.76 M
What is Hoth Therapeutics quarterly SG&A year-on-year change?
Over the past year, HOTH quarterly selling, general & administrative expenses has changed by +$116.10 K (+10.38%)
What is Hoth Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of HOTH is -$223.30 M
What is the all time high TTM SG&A for Hoth Therapeutics?
Hoth Therapeutics all-time high TTM selling, general & administrative expenses is $6.39 M
What is Hoth Therapeutics TTM SG&A year-on-year change?
Over the past year, HOTH TTM selling, general & administrative expenses has changed by -$228.68 M (-4247.27%)